Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents

被引:10
|
作者
Itriyeva, Khalida [1 ,2 ]
机构
[1] Northwell Hlth, Div Adolescent Med, Cohen Childrens Med Ctr, New Hyde Pk, NY USA
[2] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY USA
关键词
ADULT WOMENS KNOWLEDGE; BONE-MINERAL DENSITY; MEDROXYPROGESTERONE ACETATE; INTRAUTERINE-DEVICE; YOUNG-WOMEN; WEIGHT-GAIN; INNER-CITY; CONTINUATION; IMPLANTS; FAILURE;
D O I
10.1016/j.cppeds.2018.11.002
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The intrauterine devices (IUDs) and the subdermal implant, collectively known as long-acting reversible contraceptives (LARC), along with the Depo-Provera shot, represent highly efficacious methods of birth control for all reproductive-age women, including adolescents. They are also safe, private, and convenient, and can be used for their noncontraceptive benefits. Additionally, LARC and Depo-Provera represent methods of contraception that do not contain estrogen and may be safely used in young women who have contraindications to estrogen-containing medications. The LARC methods have traditionally been underused by adolescents due to lack of knowledge and misperceptions about safety and effects on future fertility. How-ever, studies have found that when barriers to the use of LARC are removed, adolescents have increasingly chosen the IUD and implant for birth control and most continue to use these methods with satisfaction. This chapter will provide an over-view of IUDs, the subdermal implant and Depo-Provera, address barriers to care for adolescents, efficacy, continuation rates, common side effects and reasons for discontinuation, contraindications, and noncontraceptive benefits.
引用
收藏
页码:321 / 332
页数:12
相关论文
共 50 条
  • [31] Post-partum Long-acting Reversible Contraception (LARC) Insertions
    Black, K.
    Paterson, H.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2019, 59 : 114 - 114
  • [32] THE PREFERENCES OF AUSTRALIAN WOMEN FOR THE OUTCOMES OF LONG-ACTING REVERSIBLE CONTRACEPTION (LARC)
    Church, J.
    Street, D.
    Bateson, D.
    Haas, M.
    VALUE IN HEALTH, 2022, 25 (01) : S218 - S218
  • [33] THE CONTRACEPTIVE USE OF DEPO-PROVERA IN UNITED-STATES ADOLESCENTS
    KOENIGS, LMP
    MILLER, NH
    JOURNAL OF ADOLESCENT HEALTH, 1995, 16 (05) : 347 - 349
  • [34] Depo-Provera vs oral contraceptive use by postpartum adolescents
    ODell, C
    Forke, C
    Polaneczky, M
    Sondheimer, S
    Slap, G
    JOURNAL OF ADOLESCENT HEALTH, 1997, 20 (02) : 127 - 127
  • [35] Relative cost effectiveness of Depo-Provera®, Implanon®, and Mirena® in reversible long-term hormonal contraception in the UK
    Susan J. Varney
    Julian F. Guest
    PharmacoEconomics, 2004, 22 : 1141 - 1151
  • [36] IMPACT OF TESTOSTERONE USE ON LONG-ACTING REVERSIBLE CONTRACEPTION (LARC) IN GENDER-DIVERSE ADOLESCENTS AND YOUNG ADULTS (AYA)
    Golub, S. A.
    Ryan, M.
    Milliren, C.
    Divasta, A.
    Pitts, S.
    CONTRACEPTION, 2023, 127 : 24 - 24
  • [37] Pediatric Provider Education and Use of Long-Acting Reversible Contraception in Adolescents
    Smith, Anna Jo Bodurtha
    Hurwitz, Anita Gupta
    Singh, Tara
    Harney, Kathleen F.
    JOURNAL OF PEDIATRIC HEALTH CARE, 2019, 33 (02) : 146 - +
  • [38] Proactive Long Acting Reversible Contraception (LARC) Provision: Adolescents' Perspectives
    Duncan, R.
    Anderson, L.
    Paterson, H.
    Pickering, N.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2017, 57 : 11 - 12
  • [39] POSTPARTUM CONTRACEPTION: A LOOK AT POSTPARTUM LONG-ACTING REVERSIBLE CONTRACEPTIVE (LARC) USE AND REPEAT PREGNANCY
    Zarecki, E.
    Wiley, C.
    Becker, D.
    Lin, J.
    CONTRACEPTION, 2019, 100 (04) : 335 - 335
  • [40] Condom use in young women using long-acting reversible contraception (LARC): a qualitative study
    Murphy, Nabreesa
    Williams, Henrietta
    Nguyen, Julie
    McNamee, Kathleen
    Coombe, Jacqueline
    Hocking, Jane
    Vaisey, Alaina
    CULTURE HEALTH & SEXUALITY, 2021, 23 (08) : 1153 - 1164